Skip to main content
Advertisement

Skyview Care: Antidepressant Wrongly Stopped - NE

Federal inspectors found that Skyview Care and Rehab at Bridgeport discontinued fluoxetine for Resident 3 on October 14 without any documented medical reason. The 10-milligram daily medication treats the resident's diagnosed major depressive disorder.

Skyview Care and Rehab At Bridgeport facility inspection

After realizing the error, staff gave the resident a one-time dose on October 16 at 1:45 PM, then restarted the regular daily schedule the following day. The Regional Nurse Consultant confirmed to inspectors on November 13 that "the order should not have been discontinued on October 14."

Advertisement

Progress notes for October contained no evidence explaining why the psychiatric medication was stopped. The resident's medical records showed fluoxetine was ordered on October 7 and began two days later, only to be inexplicably halted less than a week into treatment.

The medication confusion extended beyond psychiatric drugs. Inspectors discovered similar problems with a completely different resident's ear drops, where staff entered an order incorrectly and had to restart treatment after recognizing their mistake.

Resident 17 was supposed to receive carbamide peroxide otic solution for ear wax buildup starting October 27. The 6.5 percent solution required five drops in the right ear twice daily for eight total administrations. But nursing staff botched the initial order entry on October 21.

The Director of Nursing admitted the error during her November 13 interview with inspectors. She explained that once the facility realized the mistake, "they discussed it with the NP, and they received a new order to start the carbamide peroxide treatment again."

Both cases represent medication administration failures that federal regulators classify as having potential for actual harm to residents. The fluoxetine discontinuation particularly concerned inspectors because antidepressants require consistent dosing to remain effective for patients with major depressive disorder.

Mental health medications like fluoxetine typically take weeks to build therapeutic levels in a patient's system. Interrupting treatment can trigger withdrawal symptoms or mood destabilization, especially dangerous for residents already struggling with severe depression.

The facility's medication tracking systems failed to catch either error before they affected patient care. Monthly medication administration records documented the confusing sequence of orders for both residents but provided no explanation for the treatment interruptions.

For Resident 3, the medication record showed three separate fluoxetine entries within eight days. The original daily order lasted from October 9 to October 14. The single makeup dose appeared on October 16. The corrected daily schedule resumed October 17 and continued through the inspection period.

Staff interviews revealed the facility recognized both mistakes but only after residents had already experienced treatment gaps. The Director of Nursing and Regional Nurse Consultant both acknowledged the errors during separate conversations with federal inspectors.

The carbamide peroxide case demonstrated how medication errors can cascade through a facility's systems. What should have been a straightforward eight-day ear treatment became a multi-week process involving provider consultations and rewritten orders.

Neither resident suffered documented physical harm from the medication interruptions, leading inspectors to classify the violations as "minimal harm or potential for actual harm." However, the finding affects "some" residents, indicating the problems extended beyond these two specific cases.

The inspection occurred November 17 following a complaint about facility operations. Federal regulators found the medication administration deficiencies violated requirements for pharmaceutical services that ensure residents receive appropriate treatment and rehabilitation services.

Skyview Care and Rehab at Bridgeport must submit a plan of correction addressing how they will prevent similar medication errors. The facility operates at 505 O Street in Bridgeport, serving residents who depend on accurate medication management for conditions ranging from depression to basic ear care.

The medication mistakes highlight ongoing challenges nursing homes face maintaining accurate pharmaceutical records. When staff incorrectly enter or discontinue orders, residents can experience treatment gaps that undermine their medical care and recovery progress.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Skyview Care and Rehab At Bridgeport from 2025-11-17 including all violations, facility responses, and corrective action plans.

Additional Resources

🏥 Editorial Standards & Professional Oversight

Data Source: This report is based on official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial Process: Content generated using AI (Claude) to synthesize complex regulatory data, then reviewed and verified for accuracy by our editorial team.

Professional Review: All content undergoes standards and compliance oversight by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal, using professional regulatory data auditing protocols.

Medical Perspective: As emergency medical professionals, we understand how nursing home violations can escalate to health emergencies requiring ambulance transport. This analysis contextualizes regulatory findings within real-world patient safety implications.

Last verified: April 25, 2026 | Learn more about our methodology

📋 Quick Answer

Skyview Care and Rehab at Bridgeport in Bridgeport, NE was cited for violations during a health inspection on November 17, 2025.

Federal inspectors found that Skyview Care and Rehab at Bridgeport discontinued fluoxetine for Resident 3 on October 14 without any documented medical reason.

What this means: Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at Skyview Care and Rehab at Bridgeport?
Federal inspectors found that Skyview Care and Rehab at Bridgeport discontinued fluoxetine for Resident 3 on October 14 without any documented medical reason.
How serious are these violations?
Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
What should families do?
Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in Bridgeport, NE, (5) Report any new concerns directly to state authorities.
Where can I see the full inspection report?
The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from Skyview Care and Rehab at Bridgeport or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 285224.
Has this facility had violations before?
To check Skyview Care and Rehab at Bridgeport's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.